DNTH实时信号 | 通过Getagraph.com最大化利润

购买 116181 min ago

@ $22.91

发出时间: 9 Feb 2024 @ 01:13

回报率: -6.15%

上一信号: Feb 8 - 04:54

上一信号: 出售

回报率: -4.78 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	76 268.00
平均成交量	169 869
市值	630.96M
EPS	$0 ( 2024-03-21 )
下一个收益日期	( $-0.430 ) 2024-06-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.54
ATR14	$0.0910 (0.43%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Fairmount Funds Management Llc	Buy	58 857	Common Stock
2024-04-01	Fairmount Funds Management Llc	Sell	58 857	Common Stock
2024-01-24	Carr Edward	Buy	80 000	Stock Option (Right to Buy)
2024-01-24	Veness Adam M	Buy	110 000	Stock Option (Right to Buy)
2024-01-24	Randhawa Simrat	Buy	120 000	Stock Option (Right to Buy)

INSIDER POWER
97.86
Last 18 transactions
Buy: 6 045 948 \| Sell: 58 857

音量相关性

長: -0.04 (neutral)

短: -0.61 (weak negative)

Signal:(41.598) Neutral

Dianthus Therapeutics, 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Dianthus Therapeutics, 相关性 - 货币/商品

0.13
( neutral )

-0.46
( neutral )

0.00
( neutral )

0.59
( weak )

0.88
( strong )

0.34
( neutral )

Dianthus Therapeutics, 财务报表

Annual	2023
营收:	$2.83M
毛利润:	$2.47M (87.44 %)
EPS:	$-8.45

FY	2023
营收:	$2.83M
毛利润:	$2.47M (87.44 %)
EPS:	$-8.45

FY	2022
营收:	$6.42M
毛利润:	$6.27M (97.71 %)
EPS:	$-32.57

Financial Reports:

No articles found.

Dianthus Therapeutics,

Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. It develops DNTH103 that is in phase 1 clinical trails in patients with generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was incorporated in 2015 and is based in New York, New York.